Login or Sign Up
16:01 Jan 20
Concord Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Concord Drugs Ltd. News And Announcements
Concord Drugs Ltd.
Industry Pharmaceuticals
16:01 Jan 20
Quality
59/100
High Financial Strength
Valuation
41/100
Mid Valuation
Technical
59/100
Technically Neutral
Strength
6
Weakness
6
Opportunity
0
Threats
0
366.20
Market Cap (Cr)
-
PE Ratio
2.32
Price to Book Ratio
45.46
RSI
0.74 %
Net Profit Margin
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully